WILENTIN caps 250 mg bte 100 pce
7680679000018
CH-67900
A16AX12
07.99.0.
Reimbursement limitations:
WILENTIN
WILENTIN est remboursé pour le traitement de la maladie de Wilson (maladie de surcharge en …
1 / 2
google
Details
- Product number
- 6790002
- CPT
- -
- Packaging group
- 100
- Unit
- Kapsel(n)
- Composition
- trientini dihydrochloridum 250.00 mg, acidum stearicum, Kapselhülle: gelatina, E 171, E 110 0.44 mg, aqua, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula.
Articles (1)
Wilentin 250 mg, Hartkapseln
Kapseln
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
0.44 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2533.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 67900
- Drug name
- Wilentin, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- A16AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/12/2021
- Authorization expiration date
- 07/12/2026
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- WILENTIN caps 250 mg bte 100 pce
- Description (DE)
- WILENTIN Kaps 250 mg Ds 100 Stk
- Market launch
- 08/12/2021
- Narcotic (BTM)
- No